About 20% of your daily liquid intake comes from food and the rest from drinks
Medicines sourced from unregulated or online sellers may be counterfeit, contaminated or incorrectly dosed, and they may increase the risk of harm
PAP supports uninsured or underinsured individuals who meet income and eligibility criteria
Novo Nordisk agonist shows strong trial results as MASH cases rise among US adults For the first time, a GLP-1 therapy has been cleared to treat metabolic dysfunction-associated steatohepatitis (MASH), after the US Food and Drug Administration (FDA) granted accelerated approval to Novo Nordisks weight-loss drug Wegovy
However, a 3g HMB dose twice the 1.5g per serving in Creatine HMB would have been a better partner here, as studies typically use that amount to see benefits.6 There are some 1.5g studies that show success, but theyre the minority
Orforglipron (Foundayo): Its approval was based on the ATTAIN phase 3 trials